Eleven Biotherapeutics reports fourth quarter and full year 2016 financial results
Eleven Biotherapeutics reported net income was $1.9 million, or $0.09 per share, for the 2016 year ended, versus a net loss of $33.5 million, or $1.76 per share, in 2015. Revenue was $30.0 million for the 2016 year end, compared to $1.0 million in 2015. March 24, 2017